Credit Suisse analyst Gautam Sawant upgraded CME Group to Outperform from Neutral with an unchanged price target of $191. The analyst cites the company’s "defensive" prospects and potential to grow derivatives volumes for the upgrade. The exchanges’ sensitivity to economic conditions is a "unique revenue/earnings growth lever" due to the potential for slower economic growth, inflation ambiguity, and geopolitics to contribute to trading volume growth in 2023, Sawant tells investors in a research note. He sees more clarity on growth prospects for fixed income, commodity derivatives and index options in 2023.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CME:
- CME Group says ADV increased 7% in December to 19.2M contracts
- CME Group price target lowered to $250 from $270 at Piper Sandler
- CME Group’s Micro WTI options volume surpasses 100K contracts traded
- CME Group Declares Annual Variable Dividend
- CME Group reports November ADV increased 1% to 23.5M contracts
